Balance Sheet
Accounts PayablesAccumulated DepreciationAccumulated ExpensesAssetsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShares OutstandingTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Altimmune (ALT) Accumulated Depreciation (2016 - 2025)

Altimmune (ALT) has disclosed Accumulated Depreciation for 10 consecutive years, with $2.3 million as the latest value for Q4 2025.

  • Quarterly Accumulated Depreciation rose 5.06% to $2.3 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $2.3 million through Dec 2025, up 5.06% year-over-year, with the annual reading at $2.3 million for FY2025, 5.06% up from the prior year.
  • Accumulated Depreciation for Q4 2025 was $2.3 million at Altimmune, up from $2.2 million in the prior quarter.
  • The five-year high for Accumulated Depreciation was $2.3 million in Q4 2025, with the low at $1.1 million in Q1 2022.
  • Average Accumulated Depreciation over 5 years is $1.9 million, with a median of $1.9 million recorded in 2021.
  • The sharpest move saw Accumulated Depreciation tumbled 36.08% in 2022, then skyrocketed 31.84% in 2023.
  • Over 5 years, Accumulated Depreciation stood at $2.0 million in 2021, then dropped by 26.82% to $1.5 million in 2022, then skyrocketed by 31.84% to $2.0 million in 2023, then rose by 12.05% to $2.2 million in 2024, then rose by 5.06% to $2.3 million in 2025.
  • According to Business Quant data, Accumulated Depreciation over the past three periods came in at $2.3 million, $2.2 million, and $2.0 million for Q4 2025, Q4 2024, and Q4 2023 respectively.